Seminars in Radiation Oncology
Volume 18, Issue 4 , Pages 257-264 , October 2008

Clinical Experience Using Hypofractionated Radiation Schedules in Breast Cancer

  • Timothy J. Whelan, BM, BCh, MSc

      Affiliations

    • Department of Oncology, McMaster University, Hamilton, Ontario, Canada
    • Juravinski Cancer Centre, Hamilton, Ontario, Canada
    • Corresponding Author InformationAddress reprint requests to Timothy J. Whelan, BM, BCh, MSc, Juravinski Cancer Centre, 699 Concession Street, Rm 4-204, Hamilton, Ontario, Canada, L8V 5C2
    • ,
  • Do-Hoon Kim, MD

      Affiliations

    • Juravinski Cancer Centre, Hamilton, Ontario, Canada
    • ,
  • Jonathan Sussman, MD, CCFP, FRCP(C), MSc

      Affiliations

    • Department of Oncology, McMaster University, Hamilton, Ontario, Canada
    • Juravinski Cancer Centre, Hamilton, Ontario, Canada

References 

  1. Regaud C, Ferroux R. Discordance des Effets de rayons X, d'une part dans le testicule, par le fractionnement de la dose. C R Soc Biol. 1927;97:431
  2. Coutard H. Roentgen therapy of epitheliomas of the tonsillar region, hypopharynx, and larynx from 1920 to 1926. AJR Am J Roentgenol. 1932;28:313–331
  3. Regaud C. Sur la radio-immunisation des tissues cancéreux et sur le mécanisme de l'action des rayons X et des rayons gamma de radium sur les cellules et les tissues vivants en géneral. Bull Acad Paris. 1921;91:604
  4. Fletcher GH. Hypofractionation: Lessons from complications. Radiother Oncol. 1991;20:10–15
  5. Gallez-Marchal D, Fayolle M, Henry-Amar M, et al. Radiation injuries of the gastrointestinal tract in Hodgkins's disease: The role of exploratory laparotomy and fractionation. Radiother Oncol. 1984;2:93–99
  6. In:  Eason EC,  Pointon RCS editor. The Radiotherapy of Malignant Disease. Berlin: Springer-Verlag; 1985;
  7. Dishe S, Saunders MI. Fractionation—A review of the clinical data. Br J Radiol Suppl. 1988;22:84–87
  8. Strandqvist M. Studieren über die cumulative Wirkung der Roentgenstrahlen bei Franktionierung. Acta Radiol (Stockholm). 1944;55(suppl):40–45
  9. Ellis F. Dose, time and fractionation: A clinical hypothesis. Clin Radiol. 1969;20:1–7
  10. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679–694
  11. Lymon JT. Complication probability as assessed from dose-volume histograms. Radiat Res. 1985;8(suppl):S13–S19
  12. Horiot J, Le Fur R, N′Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol. 1992;25:231–241
  13. Brenner D. Hypofractionation for prostate cancer radiotherapy—What are the issues?. Int J Radiat Oncol Biol Phys. 2003;57:912–914
  14. Maciejewski B, Preuss-Bayer G, Trott KR. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys. 1983;9:321–328
  15. Virnig B, Habermann E, Al-Raie W, et al. Increased use of breast-conserving surgery: Preferred treatment or failure to provide adequate local therapy?. Breast Cancer. 2007;106(suppl 1):S188
  16. McCarthy EP, Ngo LH, Roetzheim RG, et al. Disparities in breast cancer treatment and survival for women with disabilities. Ann Intern Med. 2006;145:637–645
  17. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992;326:1147–1149
  18. Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial (Scottish Cancer Trials Breast Group). Lancet. 1996;348:1458–1459
  19. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update (Ontario Clinical Oncology Group). J Natl Cancer Inst. 1996;88:1659–1664
  20. Willams MV, Denekemp J, Fowler JF. A review of α/β ratios for experimental tumours: Implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys. 1985;11:87–96
  21. Steel GG, Deacon JM, Duchesne GM, et al. The dose-rate effect in human tumour cells. Radiother Oncol. 1987;9:299–310
  22. Olivotto IA, Weir LM, Kim-Sing C, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol. 1996;41:7–13
  23. Ash DV, Benson EA, Sainsbury JR, et al. Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: A report of the Yorkshire breast cancer group. Clin Oncol. 1995;7:93–96
  24. Yamada Y, Ackerman I, Franssen E, et al. Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer?. Int J Radiat Oncol Biol Phys. 1999;44:99–104
  25. Shelley W, Brundage M, Hayter C, et al. A shorter fractionation schedule for postlumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys. 2000;47:1219–1228
  26. Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94:1143–1150
  27. Whelan T, Pignol JP, Julian J, et al. Long-term results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node negative breast cancer. Breast Cancer. 2007;106(suppl 1):S6
  28. Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial. Radiother Oncol. 2005;75:9–17
  29. Owen JR, Ashton A, Bliss JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of randomised trial. Lancet. 2006;7:467–471
  30. The START Trialists’ Group. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet Oncol. 2008;9:331–341
  31. The START Trialists’ Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for the treatment of early breast cancer: a randomized trial. Lancet. 2008;371:1098–1107
  32. Yarnold J, Bloomfield D, LeVay J, et al. Prospective randomized trial testing 5.7 Gy and 6.0 Gy fractions of whole breast radiotherapy in women with early breast cancer (FAST) trial. Clin Oncol. 2004;16:S30
  33. Freedman GM, Anderson PR, Goldstein LJ, et al. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys. 2007;68:347–353
  34. Vicini FA, Arthur DW. Breast brachytherapy: North American experience. Semin Radiat Oncol. 2005;15:108–115
  35. Sanders ME, Scroggins T, Ampil FL, et al. Accelerated partial breast irradiation in early-stage breast cancer. J Clin Oncol. 2007;25:996–1002
  36. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289–293
  37. Benitez PR, Keisch ME, Vicini F, et al. Five-year results: The initial clinical trial of Mammosite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:456–462
  38. Vicini F, Beitsch PD, Quiet CA, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with Accelerated Partial Breast Irradiation (APBI). Cancer. 2008;112:758–766
  39. Vicini FA, Chen P, Wallace M, et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2007;69:1124–1130
  40. Wernicke AG, Gidea-Addeo D, Magnolfi C, et al. External beam partial breast irradiation following breast-conserving surgery: Preliminary results of cosmetic outcome of NYU 00-23. Int J Radiat Oncol Biol Phys. 2006;66(suppl 3):S32
  41. Leonard C, Carter D, Kercher J, et al. Prospective trial of accelerated partial breast intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1291–1298
  42. Kozak KR, Smith BL, Adams J, et al. Accelerated partial-breast irradiation using proton beams: Initial clinical experience. Int J Radiat Oncol Biol Phys. 2006;66:691–698
  43. Vicini F, Winter K, Straube W, et al. A Phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I/II breast carcinoma: initial report of feasibility and reproducibility of radiation therapy oncology group (RTOG) study 0319. Int J Radiat Oncol Biol Phys. 2005;63:1531–1537
  44. Olivotto IA, Whelan T, Vallis K, et al. Initial results of a Canadian feasibility study of accelerated partial breast irradiation (APBI) using 3-D conformal radiation therapy (3D CRT). Radiother Oncol. 2006;80(suppl 1):S16
  45. Magee B, Swindell R, Harris M, et al. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: Results form a randomised trial. Radiother Oncol. 1996;39:223–227
  46. Dodwell DJ, Dyker K, Brown J, et al. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol. 2005;17:618–622
  47. Veronesi U, Orecchia R, Luini A, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery experience with 590 cases. Ann Surg. 2005;242:101–106
  48. Vaidya JS, Tobias JS, Baum M, et al. Intraoperative radiotherapy for breast cancer. Lancet Oncol. 2004;5:207–208
  49. Beal K, McCormick B, Zelefsky MJ, et al. Single-fraction intraoperative radiotherapy for breast cancer: Early cosmetic results. Int J Radiat Oncol Biol Phys. 2007;69:19–24
  50. Soreli T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869–10874
  51. Koukourakis MI, Bentzen SM, Giatromanolaki A, et al. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol. 2006;24:727–735

 Dr Whelan is supported by a Canada Research Chair in Breast Cancer.

PII: S1053-4296(08)00037-4

doi: 10.1016/j.semradonc.2008.04.008

Seminars in Radiation Oncology
Volume 18, Issue 4 , Pages 257-264 , October 2008

Article Tools